Skip to main content
Have a personal or library account? Click to login
Peripheral Blood Mononuclear Cells’ Proliferative Response to Human Parvovirus B19 Antigens in Patients with Rheumatoid Arthritis / Reimatoīdā Artrīta Slimnieku Perifēro Asiņu Mononukleāro Šūnu Proliferativā Atbilde Uz Cilvēka Parvovīrusa B19 Antigēniem Cover

Peripheral Blood Mononuclear Cells’ Proliferative Response to Human Parvovirus B19 Antigens in Patients with Rheumatoid Arthritis / Reimatoīdā Artrīta Slimnieku Perifēro Asiņu Mononukleāro Šūnu Proliferativā Atbilde Uz Cilvēka Parvovīrusa B19 Antigēniem

Open Access
|Aug 2016

References

  1. Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., Combe, B., Costenbader, K. H., Dougados, M., Emery, P., Ferraccioli, G., Hazes, J. M. W., Hobbs, K., Huizinga, T. W. J., Kavanaugh, A., Kay, J., Kvien, T. K., Laing, T., Mease, P., Ménard, H. A., Moreland, L. W., Naden, R. L., Pincus, T., Smolen, J. S., Stanislawska-Biernat, E., Symmons, D., Tak P. P., Upchurch, K. S., Vencovský, J., Wolfe, F., Hawker, G. (2010). Rheumatoid Arthritis Classification Criteria. Arthritis Rheum., 62 (9), 2569-2581.
  2. Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S. (1988). The American Rheumatism Association 1987 revised criteria for the rheumatoid arthritis. Arthritis Rheum., 31 (3), 315-324.
  3. Barah, F., Vallely, P. J., Chiswick, M. L., Cleator, G. M., Kerr, J. R. (2001). Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet, 358, 729-730.
  4. Broliden, K., Tolfvenstam, T., Norbeck, O. (2006). Clinical aspects of parvovirus B19 infection. J. Int. Med., 260, 285-304.
  5. Franssila, R., Hokynar, K., Hedman, K. (2001). T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus B19. J. Infect. Dis., 183 (5), 805-809.
  6. Franssila, R., Hedman, K. (2004) T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19. Vaccine, 22 (27-28), 3809-3815.
  7. Heegard, E. D., Brown, K. E. (2002). Human parvovirus B19. Clin. Microbiol. Rev., 15, 485-505.
  8. Isa, A., Kasprowicz, V., Norbeck, O., Loughry, A., Jeffery, K., Broliden, K., Klenerman, P., Tolfvenstam, T., Bowness, P. (2005). Prolonged activation of virus-specific CD8+T cells after acute B19 infection. PLoS Med., 2 (12), e 343.
  9. Isa, A., Norbeck, O., Hirbod, T., Lundqvist, A., Kasprowicz, V., Bowness, P, Klenerman, P., Broliden, K., Tolfvenstam, T. (2006). Aberrant cellular immune responses in humans infected persistently with parvovirus B19. J. Med. Virol., 78 (1), 129-133.
  10. Kakurina, N., Kadisa, A., Lejnieks, A., Mikazane, H., Kozireva, S., Murovska, M. (2015). Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19. Medicina (Kaunas), 51 (1), 18-24.
  11. Kasprowicz, V., Isa, A., Tolfvenstam, T., Jeffery, K., Bowness, P., Klenerman, P. (2006). Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: A study of parvovirus B19. J. Virol. 80 (22), 11209-11217.
  12. Kozireva, S. V., Zestkova, J. V., Mikazane, H. J., Kadisa, A. L., Kakurina, N. A., Lejnieks, A. A., Danilane, I. N., Murovska, M. F. (2008). Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis. J. Rheumatol., 35, 1265-1270.
  13. Lindner, J., Barabas, S., Saar, K., Altmann, D., Pfister, A., Fleck, M., Deml, L., Modrow, S. (2005). CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection. J. Vet. Med. B. Infect. Dis. Vet. Public Health, 52 (7-8), 356-361.
  14. Moller, D. U., Ejbjerg, B. J., Hasselquist, M., Narvestad, E., M¸ller, J., Thomsen, H.S., ¨stergaard, M. (2008). Detection of bone erosions in rheumatoid arthritis wrist joints with magnetic resonance imaging, computed tomography and radiography. Arthritis Res Ther., 10 (1), R25.
  15. Murai, C., Munakata, Y., Takahashi, Y., Ishii, T., Shibata, S., Murryoi, T., Funato, T., Nakamura, M., Sugamure, K., Sasaki, T. (1999). Rheumatoid arthritis after parvovirus B19 infection. Ann. Rheum. Dis., 58, 130-132.
  16. Norbeck, O., Isa, A., Pöhlmann, C., Broliden, K., Kasprowicz, V., Bowness, P., Klenerman, P., Tolfvenstam, T. (2005) Sustained CD8+ T-cel responses induced after acute parvovirus B19 infection in humans. J. Virol., 79, 12117-12212.
  17. Page, C., Francois, C., Goëb, V., Duverlie, G. (2015) Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses. J. Clin. Virol., 72, 69-74.
  18. Rogo, L. D., Mokhtari-Azad, T., Kabir, M. H., Rezaei, F. (2014). Human parvovirus B19. Acta. Virol., 58 (3), 199-213.
  19. Rosenfeld, S. J., Yoshimoto, K., Kajigaya, S., Anderson, S., Young, N. S., Field, A., Warrener, P., Bansal, G., Collett, M. S. (1992). Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J. Clin. Invest., 89 (6), 2023-2029.
  20. Saikawa, T., Anderson, S., Momoeda, M., Kajigaya, S., Young, N. S. (1993). Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J. Virol., 67 (6), 3004-3009.
  21. Servant-Delmas, A., Lefrere, J. J., Morinet, F., Pillet, S. (2010). Advances in human B19 erythrovirus biology. J. Virol., 84 (19), 9658-9665.
  22. Streitz, M., Noutsias, M., Volkmer, R., Rohde, M., Brestrich, G., Block, A., Klippert, K., Kotsch, K., Ay, B., Hummel, M., Kühl, U., Lassner, D., Schultheiss, H. P., Volk, H. D., Kern, F. (2008). NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy. PLoS One, 3 (6), e2361.
  23. Stahl, H. D., Pfeiffer, R., von Salis-Soglio, G., Emmrich, F. (2000). Parvovirus B19 associated mono-and oligoarticular arthritis may evolve into a chronic inflammatory arthropathy fulfilling criteria for rheumatoid arthritis or spondylarthropathy. Clin. Rheumatol., 19, 510-511.
  24. Takahashi, Y., Murai, C., Shibata, S., Munakata, Y., Ishii, T., Ishii, K., Saitoh, T., Sawai, T., Sagamura, K, Sasaki, T. (1998) Human parvovirus as a causative agent for rheumatoid arthritis. Proc. Natl. Acad. Sci. USA, 95, 8227-8232.
  25. Tolfvenstam, T., Oxenius, A., Price, D. A., Shacklett, B. L., Spiegel, H. M., Hedman, K., Norbeck, O. (2001). Direct ex vivo measurement of CD8+ T-lymphocyte responses to human parvovirus B19. J. Virol., 75, 540-543.
  26. Van der Heijde, D. (1996). Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. Bailleres Clin. Rheumatol., 10, 435-453.
  27. Venables, P. J. W., Maini, R. N. (2013). Clinical features of rheumatoid arthritis. In: O’Dell, J. R., Romain, P. R. (eds.). UptoDate. Wolters Kluwer Health. Available at: www.uptodate.com
  28. Von Poblotzki, A., Gerdes, C., Reischl, U., Wolf, H., Modrow, S. (1996). Lymphoproliferative responses after infection with human parvovirus B19. J. Virol., 70 (10), 7327-7330.
  29. Wheeless, C. R. (2012). Rheumatoid arthritis. In: Wheeless, C. R., Nunley, J. A., Urbaniak, J. R. (eds.). Wheeless’ Text of Orthopaedics. Data Trace Internet Publishing, LLC. Available at: www.wheelessonline.com
DOI: https://doi.org/10.1515/prolas-2016-0023 | Journal eISSN: 2255-890X (formerly 1407-009X) | Journal ISSN: 1407-009X
Language: English
Page range: 175 - 181
Submitted on: Dec 21, 2015
Published on: Aug 4, 2016
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services

© 2016 Olga Bratslavska, Svetlana Kozireva, Anda Kadisa, Simons Svirskis, Aivars Lejnieks, Modra Murovska, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.